Negrotto, Laura

Defining high, medium, and low impact prognostic factors for developing multiple sclerosis

Tintore, M., Rovira, À., Río, J., Otero-Romero, S., Arrambide, G., Tur, C., Comabella, M., Nos, C., Arévalo, M. J., Negrotto, L., et al. (2015) · Brain

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 530

Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis

Negrotto, L., Farez, M. F., & Correale, J. (2016) · JAMA Neurology

Multiple Sclerosis Research StudiesAdipokines, Inflammation, and Metabolic Diseases

Cited by 198

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

Negrotto, L., Tur, C., Tintoré, M., Arrambide, G., Sastre-Garriga, J., Río, J., Comabella, M., Nos, C., Galán, I., Vidal-Jordana, A., et al. (2015) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesSystemic Lupus Erythematosus Research

Cited by 11